French Pharmaceuticals & Biotech Healthy potentially undervalued

Cellectis

Market Cap: €249.1m

A clinical stage biotechnological company, develops products based on gene-editing with a portfolio of allogeneic chimeric antigen receptor T-cells product candidates in the field of immuno-oncology and gene therapy product candidates in other therapeutic indications.

Sanofi

Market Cap: €97.8b

Engages in the research, development, manufacture, and marketing of therapeutic solutions.

Euroapi

Market Cap: €121.3m

Develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use in France, Europe, Rest of Europe, North America, the Asia Pacific, and internationally.

Vetoquinol

Market Cap: €973.1m

A veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products for cattle, pigs, dogs, and cats in Europe, the Americas, and the Asia Pacific region.

Eurofins Scientific

Market Cap: €12.2b

Provides various analytical testing and laboratory services worldwide.

Virbac

Market Cap: €3.2b

Manufactures and sells a range of products and services for companion and farm animals in Europe, North America, Latin America, East Asia, India, Africa, the Middle East, and the Pacific.